PreveCeutical Medical Inc (CNSX:PREV – Get Free Report) insider Michael Moeller purchased 650,000 shares of the firm’s stock in a transaction on Friday, March 14th. The stock was acquired at an average price of $0.03 per share, for a total transaction of $16,250.00.
PreveCeutical Medical Price Performance
PreveCeutical Medical Company Profile
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
Featured Stories
- Five stocks we like better than PreveCeutical Medical
- Best Stocks Under $10.00
- Market Momentum Shifts, But These 3 Stocks Are Built to Last
- Trading Halts Explained
- D-Wave Quantum Stock Jumps on “Quantum Supremacy” News
- Options Trading – Understanding Strike Price
- How Taiwan Semiconductor’s U.S. Move Could Shift Chipmaking
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
